File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.jcms.2012.11.042
- Scopus: eid_2-s2.0-84884205573
- PMID: 23333492
- WOS: WOS:000325835000013
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Effects of total glucosides of paeony for delaying onset of Sjogren's syndrome: An animal study
Title | Effects of total glucosides of paeony for delaying onset of Sjogren's syndrome: An animal study |
---|---|
Authors | |
Keywords | Sjogren's syndrome Sialoadenitis Total glucosides of paeony Animal model |
Issue Date | 2013 |
Publisher | Churchill Livingstone. The Journal's web site is located at http://www.elsevier.com/locate/jcms |
Citation | Journal of Cranio-Maxillofacial Surgery, 2013, v. 41 n. 7, p. 610-615 How to Cite? |
Abstract | Objective
To investigate the effectiveness of total glucosides of paeony (TGP) on Sjogren's syndrome (SS) using non-obese diabetic (NOD) mice model.
Study design
Twenty-seven 8-week-old female NOD mice were assigned into TGP group, hydroxychloroquine (HCQ) group and normal saline (NS) group, receiving corresponding drugs respectively and sacrificed at 24-week-old. Saliva flow rate (SFR), ration of regulatory T cells, level of anti-SSA/SSB, histological changes in submandibular glands (SMG) and microarray analysis were assessed. The data were analyzed using SPSS.
Results
Compared to NS group, in TGP group, SFR, SMG index and the ration of regulatory T cells were significantly higher, while anti-SSA/SSB and lymphocytic foci were significantly lower. HCQ group demonstrated similar results except SMG index. Altered gene expression was found in 10.71% of TGP and 13.09% of HCQ of the profile.
Conclusion
TGP demonstrated a similar effectiveness as HCQ in delaying the onset of SS-like disease in NOD mice. |
Persistent Identifier | http://hdl.handle.net/10722/134998 |
ISSN | 2023 Impact Factor: 2.1 2023 SCImago Journal Rankings: 1.031 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Li, CL | en_US |
dc.contributor.author | He, J | en_US |
dc.contributor.author | Li, ZG | en_US |
dc.contributor.author | Zheng, LW | en_US |
dc.contributor.author | Hua, H | en_US |
dc.date.accessioned | 2011-07-27T01:25:32Z | - |
dc.date.available | 2011-07-27T01:25:32Z | - |
dc.date.issued | 2013 | en_US |
dc.identifier.citation | Journal of Cranio-Maxillofacial Surgery, 2013, v. 41 n. 7, p. 610-615 | en_US |
dc.identifier.issn | 1010-5182 | - |
dc.identifier.uri | http://hdl.handle.net/10722/134998 | - |
dc.description.abstract | Objective To investigate the effectiveness of total glucosides of paeony (TGP) on Sjogren's syndrome (SS) using non-obese diabetic (NOD) mice model. Study design Twenty-seven 8-week-old female NOD mice were assigned into TGP group, hydroxychloroquine (HCQ) group and normal saline (NS) group, receiving corresponding drugs respectively and sacrificed at 24-week-old. Saliva flow rate (SFR), ration of regulatory T cells, level of anti-SSA/SSB, histological changes in submandibular glands (SMG) and microarray analysis were assessed. The data were analyzed using SPSS. Results Compared to NS group, in TGP group, SFR, SMG index and the ration of regulatory T cells were significantly higher, while anti-SSA/SSB and lymphocytic foci were significantly lower. HCQ group demonstrated similar results except SMG index. Altered gene expression was found in 10.71% of TGP and 13.09% of HCQ of the profile. Conclusion TGP demonstrated a similar effectiveness as HCQ in delaying the onset of SS-like disease in NOD mice. | - |
dc.language | eng | en_US |
dc.publisher | Churchill Livingstone. The Journal's web site is located at http://www.elsevier.com/locate/jcms | - |
dc.relation.ispartof | Journal of Cranio-Maxillofacial Surgery | en_US |
dc.rights | NOTICE: this is the author’s version of a work that was accepted for publication in <Journal title>. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in PUBLICATION, [VOL#, ISSUE#, (DATE)] DOI# | - |
dc.subject | Sjogren's syndrome | - |
dc.subject | Sialoadenitis | - |
dc.subject | Total glucosides of paeony | - |
dc.subject | Animal model | - |
dc.title | Effects of total glucosides of paeony for delaying onset of Sjogren's syndrome: An animal study | en_US |
dc.type | Article | en_US |
dc.identifier.email | Zheng, LW: lwzheng@hku.hk | en_US |
dc.identifier.authority | Zheng, L=rp01411 | en_US |
dc.identifier.doi | 10.1016/j.jcms.2012.11.042 | - |
dc.identifier.pmid | 23333492 | - |
dc.identifier.scopus | eid_2-s2.0-84884205573 | - |
dc.identifier.hkuros | 188919 | en_US |
dc.identifier.hkuros | 232442 | - |
dc.identifier.volume | 41 | - |
dc.identifier.issue | 7 | - |
dc.identifier.spage | 610 | - |
dc.identifier.epage | 615 | - |
dc.identifier.isi | WOS:000325835000013 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 1010-5182 | - |